Portal de Periódicos da CAPES

MRX review

2000; Wiley; Volume: 94; Issue: 5 Linguagem: Africâner

10.1002/1096-8628(20001023)94

1096-8628

Jamel Chelly,

RNA modifications and cancer

American Journal of Medical GeneticsVolume 94, Issue 5 p. 364-366 MRX review Jamel Chelly, Corresponding Author Jamel Chelly [email protected] INSERM unité 129, Paris, FranceINSERM unité 129, ICGM CHU Cochin, 24 Rue du Faubourg Saint-Jacques, 75014 Paris, France.Search for more papers by this author Jamel Chelly, Corresponding Author Jamel Chelly [email protected] INSERM unité 129, Paris, FranceINSERM unité 129, ICGM CHU Cochin, 24 Rue du Faubourg Saint-Jacques, 75014 Paris, France.Search for more papers by this author First published: 19 October 2000 https://doi.org/10.1002/1096-8628(20001023)94:5 3.0.CO;2-OCitations: 17Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Allen KM, Gleeson JG, Bagrodia S, Partington MW, MacMillan JC, Cerione RA, Mulley JC, Walsh CA. 1998. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 20: 25–30. Bienvenu T, des Portes V, de Saint Martin A, Billuart P, Carrié A, Vinet MC, Couvert P, Toniolo P, Moraine C, Beldjord C, Chelly J. 1998. Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum Mol Genet 7: 1311–1315. Billuart P, Bienvenu T, Ronce N, des Portes V, Vinet MC, Zemni R, Crollius HC, Carrié A, Fauchereau F, Cherry M, Briault S, Hamel B, Fryns JP, Beldjord C, Kahn A, Moraine C, Chelly J. 1998. Oligophrenin 1, a novel gene encoding a rho-GAP protein involved in X-linked non-specific mental retardation. Nature 392: 923–926. Birch HG, Richadson SA, Baird D, Horobin G, Ilsley R. 1970. Mental subnormality in the community: a clinical and epidemiological study. Baltimore: Williams and Wilkins. Carrié A, Jun L, Bienvenu T, Vinet MC, Van Buggenhout G, Frints S, Hamel B, Moraine C, Ropers HH, Strom T, Kahn A, Fryns JP, Beldjord C, Marynen P, Chelly J. 1999. A novel member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat Genet 23: 25–31. Chelly J. 1999. Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation. Hum Mol Genet 8: 1833–1838. D'Adamo P, Bienvenu T, Gulisano M, Menegon A, Valtorta F, Balch W, Chelly J, Toniolo D. 1998. Mutations in GDI1 are responsible for X-linked mental retardation. Nat Genet 19: 134–139. Daniels RH, Hall PS, Bokoch GM. 1998. Membrane targeting of p21-activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells. EMBO 17: 754–764. Gecz J, Gedeon A, Sutherland G, Mulley J. 1996. Identification of the gene FMR2, associated with FRAX-E mental retardation. Nat Genet 13: 105–108. Hagberg B, Kyllerman M. 1983. Epidemiology of mental retardation. A Swedish survey. Brain Dev 5: 441–449. Helmer ME. 1998. Integrin associated proteins. Curr Opin Cell Biol 10: 578–585. Lubs HA, Chiurazzi P, Arena JF, Schwartz C, Tranebjaerg L, Neri G. 1998. XLMR genes: update 1998. Am J Med Genet 64: 147–157. Maecker HT, Todd SC, Levy S. 1999. The tetraspanin superfamily: molecular facilitators. FASEB J 11: 428–442. Merienne K, Jacquot S, Pannetier S, Zenlou M, Bankier A, Gecz J, Mandel JL, Mulley J, Sassone-Corsi P, Hanauer A. 1999. A missense mutation in RPS6KA3 responsible for non-specific mental retardation. Nat Genet 22: 13–14. Moser HW, Ramey CT, Leonard CO. 1983. In: AEH Emery, DL Rimoin, editors. Principles and practice of medical genetics. Edinburgh: Churchill Livingstone. Naylor J, Brinke A, Hassock S, Green PM, Gianelli F. 1993. Characteristic mRNA abnormality found in half the patients with severe hemophilia A is due to large DNA inversions. Hum Mol Genet 2: 1773–1778. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I, Maddalena A, Spiegel R, Schinzel A, Marcos G, Schorderet DF, Schaap T, Maccioni L, Russo S, Jacobs PA, Schawartz C, Mandel JL. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet 55: 225–237. The European XLMR Consortium. 1999. X-linked nonspecific mental retardation (MRX) linkage studies in 25 unrelated families: the European XLMR consortium. Am J Med Genet 85: 263–265. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young Y, Mandel JL, Sassone-Corsi P, Hanauer A. 1996. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384: 567–570. Zemni R, Bienvenu T, Vinet MC, Billuart P, Carrié Ace N, Moraine C, van Bokhoven H, Ropers HH, Kahn A, Sefiani A, Fryns JP, Beldjord B, Chelly J. 2000. Identification of a novel gene involved in X-linked mental retardation through investigation of an X;2 balanced translocation. Nat Genet 24: 167–170. Citing Literature Volume94, Issue523 October 2000Pages 364-366 ReferencesRelatedInformation